Cholesterol Levels and Statin Use in Patients With Coronary Heart Disease Treated in Primary Care Settings

• Hoofdauteurs: Patrick J. O'Connor, MD, MPH (Auteur), Richard J. Gray, MD (Auteur), Michael V. Maciosek, PhD (Auteur), Kelly M. Fillbrandt, BS (Auteur), Terese A. DeFor, MS (Auteur), Charles M. Alexander, MD (Auteur), Thomas W. Weiss, DrPH (Auteur), Steven M. Teutsch, MD, MPH (Auteur)
• Formaat: Boek
• Gepubliceerd in: Centers for Disease Control and Prevention, 2005-07-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Introduction Therapy with 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors, or statins, has proven to be effective in the treatment of lipid disorders. However, statin therapy continues to be underused, even though statins are a relatively safe and well-tolerated class of agents....